The current clinical diagnostic of glioma is based mainly on imaging diagnostic and anatomopathological findings in biopsy pieces [16], including markers such as GFAP or Ki-67 to indicate proliferative activity, which, for this type of cerebral tumor, is especially high. Here, GFAP is linked to central nervous system cancer.